Nucleolar Protein 1 (NOL1) Antikörper (PE)
Kurzübersicht für Nucleolar Protein 1 (NOL1) Antikörper (PE) (ABIN1437267)
Target
Alle Nucleolar Protein 1 (NOL1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human NOL1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM: (1:20-100)
Optimal working dilution should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- Nucleolar Protein 1 (NOL1)
-
Andere Bezeichnung
- NOL1
-
Hintergrund
-
Synonyms: proliferation Associated Nucleolar Antigen: NOL 1, NUCLEOLAR ANTIGEN p120, NOP2_HUMAN.
Background: Proliferation-associated nucleolar antigen is expressed in mid G1 phase with peak level during the S phase and a rapid degradation during late mitosis. Its expression in breast carcinoma is correlated with patient prognosis.
-
Gen-ID
- 4839
Target
-